bluebird bio (BLUE)
(Real Time Quote from BATS)
$0.50 USD
+0.01 (1.07%)
Updated Oct 11, 2024 11:36 AM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for bluebird bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -211.91 | -266.58 | -819.38 | -618.70 | -789.61 |
Depreciation/Amortization & Depletion | 28.53 | 5.00 | 19.65 | 19.36 | 17.43 |
Net Change from Assets/Liabilities | -49.72 | -81.83 | 17.99 | -42.73 | 29.36 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -1.94 | -9.55 | 146.11 | 171.72 | 178.43 |
Net Cash From Operating Activities | -235.05 | -352.95 | -635.64 | -470.35 | -564.38 |
Property & Equipment | -4.19 | -8.21 | -14.50 | -28.99 | -71.03 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 71.08 | 161.66 | 585.56 | -55.36 | 584.06 |
Other Investing Activities | 88.06 | 97.00 | -8.50 | 0.00 | -5.22 |
Net Cash from Investing Activities | 154.95 | 250.45 | 562.56 | -84.35 | 507.81 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 248.20 | 54.25 | 80.33 | 546.72 | 21.19 |
Issuance (Repayment) of Debt | -54.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.42 | 0.00 | -174.28 | 0.00 | 0.00 |
Net Cash from Financing Activities | 196.25 | 54.25 | -93.95 | 546.72 | 21.19 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 116.15 | -48.25 | -167.04 | -7.98 | -35.39 |
Cash at Beginning of Period | 158.45 | 206.69 | 373.73 | 381.71 | 417.10 |
Cash at End of Period | 274.60 | 158.45 | 206.69 | 373.73 | 381.71 |
Diluted Net EPS | -1.93 | -3.39 | -11.89 | -9.95 | -14.31 |
Fiscal Year End for bluebird bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -151.20 | -69.80 | -211.91 | -123.40 |
Depreciation/Amortization & Depletion | NA | 32.00 | 15.47 | 28.53 | 3.12 |
Net Change from Assets/Liabilities | NA | -46.67 | -29.47 | -49.72 | -29.37 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 24.94 | 9.13 | -1.94 | -71.57 |
Net Cash From Operating Activities | NA | -140.93 | -74.68 | -235.05 | -221.21 |
Property & Equipment | NA | -1.83 | -1.78 | -4.19 | -2.98 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 71.08 | 62.08 |
Other Investing Activities | NA | 2.80 | 1.12 | 88.06 | 92.06 |
Net Cash from Investing Activities | NA | 0.97 | -0.66 | 154.95 | 151.16 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 248.20 | 129.97 |
Issuance (Repayment) of Debt | NA | 25.34 | 51.78 | -54.37 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 33.24 | 12.87 | 2.42 | 0.00 |
Net Cash from Financing Activities | NA | 58.58 | 64.65 | 196.25 | 129.97 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -81.38 | -10.69 | 116.15 | 59.92 |
Cash at Beginning of Period | NA | 274.60 | 274.60 | 158.45 | 158.45 |
Cash at End of Period | NA | 193.22 | 263.91 | 274.60 | 218.37 |
Diluted Net EPS | NA | -0.42 | -0.36 | -0.81 | -0.66 |